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Carbonic anhydrase III (CA III) was identified in the products of rat soleus muscle RNA translation in 
vitro by both a radioimmunoassay and a specific immunoprecipitation technique followed by SDS-poly- 
acrylamide gel electrophoresis analysis of the precipitated antigen. The primary translation product has 
the same Mr-value as the native isoenzyme. CA III mRNA was found to represent -0.55s”c of the total 
mRNA present in rat soleus muscle. 
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1. INTRODUCTION 
Recently the low-activity, sulphonamide-resis- 
tant carbonic anhydrase III (CAIII) isoenzyme has 
been characterised from skeletal muscle of the rat 
[I] and shown to be expressed at particularly high 
concentrations in both male and female soleus 
muscle 121. Despite the relative abundance of 
CA111 in mammalian skeletal muscle 13-81. rela- 
tively little is known about its true physiological 
function, or about the underlying mechanisms 
which control its gene expression. There is strong 
evidence that this muscle CA111 and a structurally 
indistinguishable carbonic anhydrase isoenzyme, 
which is present at high concentration in the liver 
of the male rat (21, are products of the same genetic 
locus. The hormonal regulation of liver CAIII is 
believed to be complex [9] and it is expected that 
this isoenzyme will prove to be a valuable marker 
for studies on the hormonal control of mammalian 
gene expression. A limited number of reports have 
described a single-step antibody precipitation of 
the red-cell carbonic anhydrase I isoenzyme, trans- 
lated in vitro [ 10.1 11, however the immunoreactive 
polypeptide was not further characterised. The in- 
ability to detect and quantitate CA111 mRNA has 
hampered the investigation of the mechanisms 
involved in controlling its expression. Here, we 
report the development of a method for the suc- 
cessful immunoprecipitation of CA111 from the 
products of rat soleus muscle RNA transla!ed in 
vitro. 
2. MATERIALS AND METHODS 
2.1. RNA isolation and translation in vitro 
Total RNA was isolated from 10 g rat soleus 
muscle using the guanidinium thiocyanate extrac- 
tion procedure [ 121 and tested for biological ac- 
tivity by translation in an mRNA-dependent rab- 
bit reticulocyte lysate (Amersham International) 
1131. After denaturation at 68°C for 2 min followed 
by rapid cooling in a mixture of ice and water the 
RNA (final cont. 50-250 pg/ml) was incubated in 
80% (v/v) lysate for 90 min at 30°C either in the 
absence or presence of 1 &i/p1 of [35S]meth- 
ionine (Amersham). Translational activity was de- 
termined by liquid scintillation counting of acid- 
precipitable radioactivity from the 35S-labelled 
products as described in the lysate batch analysis 
sheet provided by Amersham. 
2.2. Immunoprecipitation with Staphylococcus 
aureus cells 
Rabbit antisera to rat muscle CA111 and a liver 
microsomal membrane cytochrome P450 (PB 
P450) were prepared as in 12,141. Fixed Staphylo- 
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coccus aureus cells [15] were obtained from 
Michelle Ginsberg of the Imperial Cancer Re- 
search Fund Laboratories (Lincoln’s Inn Fields, 
London) and prepared for precipitation of the pri- 
mary antibody immunoprecipitation complex as in 
[ 131. The general immunoprecipitation procedure 
is described below with any modifications outlined 
in the legends to lig.2,3. 
Translation products (- 6 x 105 acid-precipitable 
cpm) were made 1% (v/v) with respect to sodium 
deoxycholate and diluted with 500 ~1 0.5% Triton 
X-100, 0.5% sodium deoxycholate in NET buffer 
(150 mM NaCl, 5 mM EDTA, 50 mM Tris-HCl 
(pH 7.4) 0.02% NaN3, 2 mM methionine). The di- 
luted translation products were then adjusted to 
ImM phenylmethylsulphonylfluoride, 100 u 
aprotinin/ml (Sigma) and 200 PLg ovalbumin/ml or 
bovine serum albumin. The appropriate antiserum 
or non-immune rabbit serum (5 ~1) was then added 
and the mixture incubated at 30°C for 30 min. Fix- 
ed Staphylococcus aureus cells (50 ~1 of a 10% SUS- 
pension) were added and the samples were agi- 
tated by rotation at 4°C overnight. The cells were 
pelleted, washed and the immunoprecipitated pro- 
tein was eluted as in 1131. The final supernatants 
were made 2% (v/v) with respect to mercaptoeth- 
anol and heated at 100°C for 3 min. 
2.3. Immunoprecipitation with IgG-Sepharose and 
protein A-Sepharose 
Goat anti-rabbit IgG (Miles-Yeda) was coupled 
to cyanogen bromide activated Sepharose4B 
(Pharmacia) as in [16]. Protein A-Sepharose was 
purchased from Pharmacia. Goat anti-rabbit 
IgG-Sepharose (60 pg IgG in 20 ~1) or protein A- 
Sepharose (40 pg protein A in 20 ~1) were substi- 
tuted for the S. aureus cell in the above immuno- 
precipitation, as indicated in tig.2. 
2.4. SDS gel electrophoresis andjluorography 
Total translation products and immunoprecipi- 
tates were analysed by electrophoresis in poly- 
acrylamide gels containing SDS followed by fluo- 
rography as in [ 131. 
2.5. Determination of radioactivity in immunopre- 
cipitates 
Radioactive bands were excised from gels and 
radioactivity was determined by liquid scintillation 
spectrometry as in 1131. 
2.6. Radioimmunoassay of translation products 
Non-radioactively labelled translation products 
(20-30 ~1) were incubated with 100 ~1 of a l/5000 
dilution of rat CA111 antiserum for 48 h at 4°C. 
t*sI-Labelied rat CA111 ( - I5 000 cpm in 100 ~1) 
was added and the incubation was continued for a 
further 24 h. The antibody-bound phase was pre- 
cipitated by overnight incubation at 4°C with 
100 ~1 of a l/20 dilution of donkey-anti-rabbit y- 
globulin (Wellcome Reagents) and then collected 
by centrifugation (1000 x g for 30 min) at 4°C. 
Radioactivity was measured in the precipitates 
using a programmable y-counter (LKB 1270 Rack- 
gamma1 ) and displacement of cpm converted 
into concentration of CA111 by extrapolation from 
a standard curve. 
3. RESULTS AND DISCUSSION 
CA111 was detected in the products of rat soleus 
muscle total RNA translated in vitro by radioim- 
munoassay. The amount of CA111 increased with 
increasing RNA concentration, reaching a max- 
imum at 250 pg RNA/ml (fig.lA). A time course of 
translation showed that after a short lag, CA111 
ME tminl 
Fig.1. Radioimmunoassay of CA111 in the products of 
rat soleus muscle total RNA translated in a cell-free pro- 
tein synthesizing system. RNA was translated at various 
concentrations of 90 min in the absence of labelled 
methionine (A) or RNA was translated for various times 
at 250 &ml final cont. in the absence of labelled meth- 
ionine (B). The amount of CA111 synthesized was deter- 
mined by radioimmunoassay as described in section 2.6. 
The sensitivity of the radioimmunoassay was in the 
region of 250 ng CAIIMitre. 
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Fig.2. Determination of optimal conditions for the im- 
munoprecipitation of CA111 from the products of rat 
soleus muscle RNA translation in vitro. SDS-lo% poly- 
acrylamide gel electrophoretic analysis of total transla- 
tion products (a); polypeptides immunoprecipitated by 
CA111 antiserum with S. aureus cells (b-e), goat anti- 
rabbit IgG-Sepharose (f-i) or protein A-Sepharose 
(k-m). Translation products were subjected to either a 
short (f,hj,l) or long (b-e,g,i,k,m) immunoprecipitation. 
The short immunoprecipitation involved incubation 
with CA111 antiserum at 20°C for 15 min, followed by 
the addition of the second component of the reaction 
and further incubation at 4°C for 30 min. Long reac- 
tions were for 30 min at 30°C in the presence of the first 
antibody and then at 4°C overnight in the presence of 
the second component. Immunoprecipitations were 
done in the presence of either 0.05% NP40 (b,c,f,gj,k) 
or 0.5% sodium deoxycholate/0.5% Triton X-100 
(d,e,h,i,l,m). Samples in tracks b,d were boiled for 2 min 
in the presence of 2% SDS before immunoprecipitation. 
Sample in track n was treated identically to that in track 
g except that non-immune serum was used instead of 
CA111 antiserum. Molecular weight markers were run in 
track o. Numbers give M,-values of marker proteins 
( X 10 -3). Gel was fluorographed for 11 days. 
concentration increased linearly up to about 
40 min and then plateaued (fig.lB). 
When translated in reticulocyte lysate in the 
presence of [35S]methionine the translational effi- 
ciency of total cellular RNA extracted from rat sol- 
eus muscle was 3 X 105 dpm/pg RNA. The RNA 
directed the synthesis of a wide spectrum of poly- 
peptides up to Mr 200 000 (fig.2a). Two of the 
major products had M,-values of about 45 000 and 
17 000. 
Fig.3. Immunoprecipitational analysis of CA111 in the 
translation products of rat soleus muscle RNA. Transla- 
tion products of rat soleus muscle RNA were incubated 
with 5 ~1 non-immune serum (a), 5 ~1 CA111 antiserum 
(b,g-j), 10 ~1 CA111 antiserum (c), 5 ~1 CA1 antiserum 
(d) or 5 ~1 (30 pg) anti-(PB P450) IgG. Before addition 
of CA111 antiserum, samples in tracks g-j were mixed 
with 0.1 (g), 0.5 (h), 2.5 (i) or 5.0 pg (j) of purified CAIII. 
Track f represents the material immunoprecipitated by 
5 ~1 CA111 antiserum from rabbit reticulocyte lysate in- 
cubated in the absence of exogenous RNA. Antigen- 
antibody complexes were precipitated with S. aureus 
cells and electrophoresed on SDS-13% polyacrylamide 
gels as in section 2. Gel was fluorographed for 3 days. + 
marks the origin of the gel. Numbers give M,-values of 
marker proteins (X 10~~). 
To establish optimum conditions for the immu- 
noprecipitation of CA111 from translation products 
we investigated the effect of varying the detergent 
concentration, length of incubation and the re- 
agent used to precipitate the soluble primary anti- 
body-antigen complex. Immunoprecipitation was 
done as in section 2 with modifications as in fig.2 
and immunoprecipitated material was analysed by 
SDS-polyacrylamide gel electrophoresis (fig.2). 
Whereas the short-term incubations (tig.2f,hj,l) 
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were relatively unsuccessful, all the long-term in- 
cubations (tig2b-e,g,i,k,m) resulted in the immu- 
noprecipitation of a polypeptide of Mr 28 000, the 
same as that of purified rat CAIII. The use of S. 
aureus cells as the precipitating agent (tig.2b-e) 
resulted in the immunoprecipitation of twenty 
times as much of this protein as did either goat 
anti-rabbit IgG-Sepharose (fig.2g,i) or protein A- 
Sepharose (lig,2k,m). Varying [detergent] from 
0.05% NP40 to 0.5% sodium deoxycholate/OS% 
Triton X-100 had no effect on the immunoprecipi- 
tation but boiling the translation products in 2% 
SDS before immunoprecipitation resulted in the 
precipitation of additional polypeptides (fig.2b,d). 
Based on the above results the conditions used 
in tig.2e (described in section 2.2) were selected for 
all subsequent immunoprecipitations of CAIII. 
Using these conditions, CA111 antiserum immuno- 
precipitated a single polypeptide of Mr 28 000 
(fig.3b) from the products of rat soleus muscle 
mRNA translation in vitro. CA111 antiserum did 
not precipitate this polypeptide from reticulocyte 
lysate that had been incubated at 30°C for 90 min 
in the absence of any exogenous mRNA (tig.30. 
Nothing was precipitated from translation prod- 
ucts of soleus muscle RNA by non-immune anti- 
serum (tig.3a), rat CA1 antiserum (tig.3d), or anti- 
(PB P450) IgG (fig.3e). 
Purified rat CA111 competed with the immu- 
noprecipitated translation product for antigen- 
binding sites of CA111 antiserum (tig.3g-j), where- 
as no competition was observed with ovalbumin or 
bovine serum albumin (not shown). Thus, the im- 
munoprecipitation is specific for CA111 antiserum 
and the Mr 28 000 protein has antigenic sites com- 
mon to those of purified CAIII. Doubling the 
amount of CA111 antiserum used had no effect on 
the amount of CA111 immunoprecipitated (fig.3c) 
and it was known that the S. aureu.s cells were in 
excess [ 131, indicating that the immunoprecipita- 
tion of CA111 was quantitative. 
Having established the presence in rat soleus 
muscle of mRNA coding for CA111 it was possible 
to use the immunoprecipitation reaction to quan- 
tify this mRNA. CA111 mRNA was found to repre- 
sent about 0.55% of the total mRNA present in 
that tissue. This figure is dependent on the as- 
sumption that, under the conditions used, the efti- 
ciency of translation of the CA111 mRNA is equal 
to the average translational efficiency of the total 
mRNA population, and that CA111 has an average 
content of methionine residues. However, methio- 
nine represents only - 1% of the amino acids in rat 
CA111 [l] and this is less than the average methio- 
nine content found in sequence mammalian pro- 
teins or predicted from codon frequencies [17]. 
Therefore, it is possible that the proportion of 
CA111 mRNA in rat soleus muscle is of the order 
of l-2% and this is fairly close to the proportion of 
CA111 protein in total rat soleus muscle proteins 
(about 4%) as determined by immunoassay 121. 
The reason that CA111 mRNA is present in a lower 
proportion than the protein could be due to the 
CA111 protein and/or mRNA having a longer than 
average half-life. 
We have described a method for the selective 
immunoprecipitation of CA111 synthesized in a 
cell-free protein synthesizing system. The primary 
translation product of rat soleus muscle CA111 
mRNA has the same M,-value as the native en- 
zyme (i.e., 28 000) and apparently does not under- 
go extensive post-translational modification. The 
immunoprecipitation technique should prove valu- 
able in the investigation of the developmental and 
hormonal regulation of CA111 gene expression. 
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